Northrim BanCorp (NRIM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Astronics Corporation (ATRO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Aris Mining Corporation (ARMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The foot is still firmly on the gas when looking at the next few years of “AI” within large-cap tech, communication services and consumer discretionary. The one red flag that is waving is that after +25% returns for the S&P 500 in 2023 and 2024 and now a YTD return for the benchmark as of 11/15/25 of +15.65%, usually the 4th year is low-single-digits or negative. 2026 could be a tougher year, even with the expected 14% EPS growth rate next year, although this blog said the same thing at roughly the same time last year.

Datavault AI Inc. (NASDAQ: DVLT) shares climbed Monday after the company reported strong quarterly earnings and a bold increase in its financial guidance for 2025 and 2026.

CNS Pharmaceuticals, Inc. ( CNSP ) Shareholder/Analyst Call November 17, 2025 12:00 PM EST Company Participants John Climaco - CEO, President & Director Christopher Downs - Chief Financial Officer Presentation John Climaco CEO, President & Director Welcome, everyone. The Annual Meeting of the Stockholders of CNS Pharmaceuticals, Inc. is hereby convened and called to order.

Johnson & Johnson ( JNJ ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM EST Company Participants Candice Long - Worldwide Vice President of Immunology David Lee - Global Therapeutic Area Head, Immunology for Janssen Pharmaceutical Conference Call Participants Alexandria Hammond - Wolfe Research, LLC Presentation Alexandria Hammond Wolfe Research, LLC Good morning, everybody. My name is Alex Hammond, and I'm the biopharma analyst here at Wolfe.

BeOne Medicines AG ( ONC ) Jefferies London Healthcare Conference 2025 November 17, 2025 11:00 AM EST Company Participants John Oyler - Co-Founder, Executive Chairman & CEO Aaron Rosenberg - Chief Financial Officer Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors Conference Call Participants Yuxi Dong - Jefferies LLC, Research Division Presentation Yuxi Dong Jefferies LLC, Research Division All right. Good afternoon, everyone.

LYFT misses Q3 estimates but delivers solid revenue and bookings gains as cash rises. The company offers an upbeat Q4 outlook.

If someone calls and threatens to immediately shut off the power, it's likely fraudulent UNIONDALE, N.Y. , Nov. 17, 2025 /PRNewswire/ -- Scammers are leveraging the stresses of the holiday season against households and businesses on Long Island and in the Rockaways, impersonating PSEG Long Island and area utilities and demanding immediate payment to prevent a shutoff.

This article analyzes the consumer discretionary sector using value, quality, and momentum metrics for top-down evaluation. Consumer services subsector stands out as undervalued and high quality, while auto/components are overvalued with weak quality scores. FDIS and XLY are similar for long-term investors based on fees and risk-adjusted returns; both have high exposure to Amazon and Tesla.

AUSTIN, Minn. , Nov. 17, 2025 /PRNewswire/ -- Hormel Foods Corporation, (NYSE: HRL), a Fortune 500 global branded food company, today announced it has once again been named on Military Times' 2025 Best for Vets employer list for the 13th consecutive year.

Lowe's Companies, Inc. remains resilient with strong fundamentals and growing Pro segment exposure but faces inflationary headwinds and limited upside. LOW appears fully valued at current prices, with technicals showing bearish signals and downside price risks outweighing near-term upside potential. Robust liquidity, prudent debt management, and strategic geographic presence help LOW weather market challenges, but Home Depot offers better fundamentals and upside.

Fiverr (FVRR) is undergoing a strategic up-market shift, focusing on high-quality talent and larger business projects despite AI-driven disruption. FVRR delivered strong Q3 results, with 8% revenue growth, record operating margins, and robust free cash flow, and the stock only trades at 9x FCF. The platform's up-market tools and AI talent base are driving higher spend per buyer and rapid growth in managed services and tech categories.

SOUN's $269M cash stash is fueling bold AI moves, from new platforms to acquisitions and global enterprise expansion.

Broadcom Inc. (AVGO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Bank of America plans to spend billions of dollars on technologies such as artificial intelligence to boost bankers' productivity and bring in more revenue, its chief technology and information officer said on Monday.

Regeneron Pharmaceuticals, Inc. ( REGN ) Jefferies London Healthcare Conference 2025 November 17, 2025 10:30 AM EST Company Participants Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Christopher Fenimore - Executive VP of Finance & CFO Conference Call Participants Akash Tewari - Jefferies LLC, Research Division Presentation Akash Tewari Jefferies LLC, Research Division Thanks so much, everyone. It's funny.

Eledon Pharmaceuticals, Inc. ( ELDN ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 12, 2025 10:30 AM EST Company Participants Steven Perrin - President, Chief Scientific Officer & Non Independent Director Conference Call Participants Vamil Divan - Guggenheim Securities, LLC, Research Division Presentation Vamil Divan Guggenheim Securities, LLC, Research Division All right. Thanks, everyone, for joining us here on the Second Annual Guggenheim Healthcare Innovation Conference.

The market-wide AI-related correction has already triggered CRWV's cheaper valuation, with the expanding multi-year backlog sustaining its high-growth thesis. The recent project delays and the intensified capex cadence are likely to contribute to the neocloud's robust FY2026 top-line performance, despite the tougher YoY comparison. As a result of the 2Y+ time lag between the capex and revenue recognition, it is unsurprising that CRWD's balance sheet continues to deteriorate.